GeniPhys Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Later Stage VC
  • (In Progress)
  • Latest Deal Amount
  • $5M
Latest Deal Amount
  • Investors
  • 3

GeniPhys General Information


Operator of an early-stage regenerative medicine company intended to develop and commercialize its patented technology. The company's technology is a first-of-a-kind polymerizable (scaffold-forming) collagen that supports the custom design and fabrication of collagen materials for accelerated and improved tissue restoration and regeneration, enabling medical researchers to offer potential material applications that extends from regenerative tissue replacements (including soft tissue, cardiovascular, musculoskeletal, and orthopedic) to delivery of pharmaceutical and cell-based therapies and to a sensor/device coatings.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • 10307 Oak Ridge Drive
  • Zionsville, IN 46077
  • United States
+1 (317) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeniPhys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC $5M 00.00 In Progress Pre-Clinical Trials
5. Grant 01-Jul-2019 00000 00000 Completed Pre-Clinical Trials
4. Early Stage VC 10-Jan-2017 0000 00000 Completed Startup
3. Early Stage VC 19-May-2015 0000 00000 Completed Startup
2. Angel (individual) $100K $100K Completed Startup
1. Accelerator/Incubator Completed Startup
To view GeniPhys’s complete valuation and funding history, request access »

GeniPhys Patents

GeniPhys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3052266-A1 Methods and compositions for matrix preparation Pending 31-Jan-2017 000000000
EP-3576775-A1 Methods and compositions for matrix preparation Pending 31-Jan-2017 000000000
US-20200246507-A1 Methods and compositions for matrix preparation Pending 31-Jan-2017 00000000000
JP-2020505474-A Methods and compositions for the preparation of substrates Pending 31-Jan-2017 000000000
EP-3576775-A4 Methods and compositions for matrix preparation Pending 31-Jan-2017 C07K14/78 0

GeniPhys Executive Team (3)

Name Title Board Seat Contact Info
Andrew Eibling Chief Executive Officer, President & Board Member
Sherry Harbin Ph.D Founder, CSO & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

GeniPhys Board Members (2)

Name Representing Role Since
R. Neff JD Self Chairman 000 0000
Sherry Harbin Ph.D GeniPhys Founder, CSO & Board Member 000 0000
To view GeniPhys’s complete board members history, request access »

GeniPhys Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GeniPhys Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government Minority 000 0000 000000 0
Elevate Ventures Venture Capital Minority 000 0000 000000 0
Purdue Research Foundation Limited Partner 000 0000 000000 0
To view GeniPhys’s complete investors history, request access »